Urological cancer, Malmö
281 – 290 of 499
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Galiellalactone is a Direct Inhibitor of STAT3 in Prostate Cancer Cells.
(
- Contribution to journal › Article
-
Mark
Androgen receptor polymorphism dependent variation in prostate specific antigen concentrations of European men.
(
- Contribution to journal › Article
-
Mark
Cancer-associated Changes in the Expression of TMPRSS2-ERG, PCA3, and SPINK1 in Histologically Benign Tissue From Cancerous vs Noncancerous Prostatectomy Specimens.
(
- Contribution to journal › Article
-
Mark
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer.
(
- Contribution to journal › Article
-
Mark
TCF7L2 type 2 diabetes risk variant, lifestyle factors, and incidence of prostate cancer.
(
- Contribution to journal › Article
-
Mark
Identification of plasma protein profiles associated with risk groups of prostate cancer patients.
(
- Contribution to journal › Article
-
Mark
The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication.
(
- Contribution to journal › Article
-
Mark
Interobserver variability in the pathological assessment of radical prostatectomy specimens: Findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
(
- Contribution to journal › Article
-
Mark
Tractable and Reliable Registration of 2D Point Sets
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Plasma alkylresorcinol metabolites as biomarkers for whole-grain intake and their association with prostate cancer: a Swedish nested case-control study.
(
- Contribution to journal › Article